lab-to-market gap – Federal R&D investment has fallen below 1% of GDP while overall spending hits historic highs largely led by the private sector. The shift is reshaping the lab-to-market pipeline—raising whether deep, long-horizon technologies like quantum will get the early ba
For much of the past century, the United States treated innovation like a long game—one it didn’t fully trust to chance.
At the height of the Space Race in the 1960s, federal investment in research and development reached nearly 2% of GDP. Today, that number has fallen below 1%. In parallel, total R&D spending has climbed to historic heights, powered primarily by the private sector.
That widening divide is not a modern accident. It’s an old rhythm, swinging between public and private leadership—first echoed in the private sector-led industrial revolution, then reshaped by the post-WWII boom of government agencies that helped unlock breakthroughs across science and technology.
Now, the question has sharpened around slower, deep technologies. In an innovation economy increasingly driven by private capital. and with federal agencies described here as having been unwound. the anxiety is straightforward: will private investors step into the lab-to-market gaps. or will technologies that are nearing commercialization stall?.
The answer, in this moment, is already being written by policy choices—and by who is willing to fund what comes before the first real market signal.
A system built in phases
The modern innovation economy didn’t emerge in a single decision. It formed through distinct phases of public and private investment.
In the early 20th century, innovation was largely decentralized and privately driven. Individual inventors and corporate laboratories focused on immediate technical challenges tied to commercial opportunity. The model helped transform industries, but it also produced siloed systems.
World War II changed the equation. Federal investment surged, and a new model coordinated universities, industry, and national laboratories. That approach carried forward into the Cold War. when public funding became the dominant force in American R&D and a demonstration of might—supporting areas ranging from semiconductors to aerospace and computing.
By the 1960s, the federal government funded more than two-thirds of all research and development in the United States.
From breakthrough to market
By the late 1970s, another problem emerged. The U.S. was producing major scientific discovery, but much of it wasn’t translating into real-world applications.
The Bayh-Dole Act of 1980 aimed at that gap. It allowed universities and research institutions to retain ownership of federally-funded inventions. With that ownership structure in place, private companies could license and commercialize new technologies—helping unlock a wave of economic activity.
The policy shift created conditions for companies like Google, Yahoo, and Qualcomm. Since passage, university-led innovation has contributed more than $1.3 trillion to the U.S. economy and supported millions of jobs. The framework described here is a more complete system: public funding supported discovery. and private capital scaled and deployed those discoveries into the market.
A shift back to private leadership
In more recent decades, the balance described in the source material has tilted again. Business now funds roughly 75% of all U.S. R&D, while the federal share has declined to 18%.
The shift isn’t framed as a simple story of shrinking public investment in absolute terms. Instead, it’s tied to the rapid expansion of private-sector research driven by global competition and the rise of technology-driven industries.
At the same time, the federal government narrowed its focus. As of 2021, it remained the largest funder of basic research, supporting 40% of foundational (basic) scientific work, while largely stepping back from later-stage development.
In theory. the division of labor makes sense: private capital is described as strong at scaling technologies. improving efficiency. and bringing products to market. It is said to be less suited to research that is high-risk. capital-intensive. long-horizon. and without immediate commercial application—an area the source describes as historically filled by public investment.
The biggest structural tension comes in the space between lab and market. The material argues that private investment depends on stable policy environments, while long-horizon technologies can struggle in markets where regulatory frameworks, incentives, and funding structures shift every few years.
Innovation is a system, not a program
The debate between public and private funding, in this account, misses the core problem. Innovation is described as a system, not a single pipeline or a single funding line.
It depends on coordinated inputs across research institutions, industry, government, and capital markets. It also depends on continuity, infrastructure, and a clear pathway from discovery to deployment. When one part weakens, the effects compound.
Research capacity, the source stresses, isn’t easily switched on and off. When federal labs or university programs lose funding, talent disperses, institutional knowledge erodes, and progress resets—and rebuilding capacity takes years.
Commercialization doesn’t automatically follow discovery either. Without systems connecting research to industry, even promising discoveries can stall—an argument that puts “ecosystems” at the center.
Innovation hubs such as Greentown Labs and mHUB—and the source specifically notes mHUB and mHUB Ventures—are described as operating at that intersection by connecting startups. industry. and research to accelerate the path from breakthrough to commercialization. They are presented as providing infrastructure. partnerships. and an environment that can translate breakthroughs into real-world applications. but only if elements move in alignment and players show up under conditions agreeable to all.
The experiment underway
The United States is described as running a real-time experiment as it moves into a new era of emerging technologies: whether the public-private balance will be actively maintained or passively eroded.
The source points to $2 billion in incentives for the quantum ecosystem announced by the CHIPS Research and Development Office. It also references newer initiatives such as the Genesis Mission.
The central warning is that if private capital is expected to play a larger role. it cannot remain concentrated only at the point of commercialization. It needs to move upstream—investing earlier in technologies before markets are fully defined. supporting research environments that may not produce immediate returns. and participating in systems that connect discovery to deployment rather than waiting for market-ready solutions.
In this framing, the future of innovation will be determined by how these forces align and by who steps forward to build what comes next.
Haven Allen is CEO and cofounder of mHUB and mHUB Ventures.
R&D funding federal research and development quantum ecosystem CHIPS Research and Development Office Bayh-Dole Act of 1980 deep technologies innovation ecosystem Greentown Labs mHUB mHUB Ventures lab-to-market gap basic research venture capital
So basically nobody’s funding quantum anymore? Cool.
I don’t get why it says federal fell below 1% but spending is at historic highs?? Like where’s the money going then, Amazon? quantum sounds like sci-fi.
My cousin works in tech and he said all the grants got cut because of “unwound agencies” which I’m guessing means they just stopped caring. But then it says private sector is doing it, so… does that mean private companies get all the profit and we get nothing? Seems backwards.
I swear these articles always come down to “the lab-to-market gap” like it’s a mystery. If quantum is “deep, long-horizon,” then why would you expect it to be funded quickly? Also $2B sounds like chump change for the government, like they should just do what they did in the 60s. Space Race comparison feels misleading though, since satellites aren’t the same as quantum whatever.